THE Royal Australian and New Zealand College of Psychiatrists has just published its first guidelines for psychedelic-assisted therapy, taking a conservative approach to what it describes as a "developing" field for which evidence is either limited or emerging, SMH has reported.
"MDMA and magic mushrooms are not miracle cures for mental illnesses and Australia must approach them cautiously," the body stated.
The TGA has announced that authorised psychiatrists would be able to prescribe MDMA to assist treatment of post-traumatic stress disorder and psilocybin, the active ingredient in magic mushrooms, for treatment-resistant depression.
The change takes effect on 01 Jul, and treatment is initially expected to cost $25,000 or more out-of-pocket.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jun 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jun 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
